Literature DB >> 15668870

Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.

Flavia B Lillo1, Sara Lodini, Davide Ferrari, Carol Stayton, Gianluca Taccagni, Laura Galli, Adriano Lazzarin, Caterina Uberti-Foppa.   

Abstract

BACKGROUND: The role of human papillomavirus (HPV) load and the importance of multiple-strain HPV infections as biomarkers for the development of cervical disease were evaluated in human immunodeficiency virus (HIV)-positive women.
METHODS: A total of 108 samples were analyzed, 64 of which were obtained from 16 HIV-positive women who underwent surgical resection of the cervical cone for treatment of a histologically confirmed high-grade cervical intraepithelial neoplasm (cases) and 44 of which were obtained from 22 HIV-positive women who had high-risk HPV but a negative colposcopy result (controls). Each patient underwent periodic examinations at 6-12-month intervals that included colposcopy, Papanicolaou testing, biopsy (if indicated), and cervical brushing for HPV testing. Viral typing was performed by reverse dot-blot hybridization and quantification of viral load by in-house real-time PCR and commercial assays.
RESULTS: Analysis of the cervical-brush samples collected when high-grade squamous intraepithelial lesions were diagnosed revealed that all cases had HPV loads that were significantly higher than those of controls (P=.0004 and P=.0003, by PCR and the Hybrid Capture 2 index [Digene], respectively). Decreasing concentrations of HPV load were observed when comparing samples obtained before and after treatment (P<.0001). The number and type of HPV strains that were detected were not statistically different between cases and controls.
CONCLUSIONS: The significantly higher HPV load detected in women with high-grade cervical dysplasia, as well as the dramatic decrease in the load after surgical removal of the lesion, suggest that HPV load is a possible prognostic marker of high-grade SIL.

Entities:  

Mesh:

Year:  2005        PMID: 15668870     DOI: 10.1086/427032

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  [Human papilloma virus-induced disease in HIV-positive patients].

Authors:  R Wienecke; N H Brockmeyer; A Kreuter
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

2.  Physical state and viral load as predictive biomarkersfor persistence and progression of HPV16-positive cervical lesions: results from a population based long-term prospective cohort study.

Authors:  Anna Manawapat; Frank Stubenrauch; Rainer Russ; Christian Munk; Susanne Kruger Kjaer; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

3.  CD4+ T cells against human papillomavirus-18 E7 in patients with high-grade cervical lesions associate with the absence of the virus in the cervix.

Authors:  Samantha Seresini; Massimo Origoni; Luigi Caputo; Flavia Lillo; Renato Longhi; Simone Vantini; Anna Maria Paganoni; Maria Pia Protti
Journal:  Immunology       Date:  2010-06-02       Impact factor: 7.397

4.  Kinetics of DNA load predict HPV 16 viral clearance.

Authors:  M Marks; P E Gravitt; U Utaipat; S B Gupta; K Liaw; E Kim; A Tadesse; C Phongnarisorn; V Wootipoom; P Yuenyao; C Vipupinyo; S Rugpao; S Sriplienchan; D D Celentano
Journal:  J Clin Virol       Date:  2011-03-09       Impact factor: 3.168

5.  Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.

Authors:  Rachel L Winer; Tiffany G Harris; Long Fu Xi; Kathrin U Jansen; James P Hughes; Qinghua Feng; Carolee Welebob; Jesse Ho; Shu-Kuang Lee; Joseph J Carter; Denise A Galloway; Nancy B Kiviat; Laura A Koutsky
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

6.  High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.

Authors:  Patti E Gravitt; Melinda Butsch Kovacic; Rolando Herrero; Mark Schiffman; Concepcion Bratti; Allan Hildesheim; Jorge Morales; Mario Alfaro; Mark E Sherman; Sholom Wacholder; Ana-Cecilia Rodriguez; Robert D Burk
Journal:  Int J Cancer       Date:  2007-12-15       Impact factor: 7.396

7.  Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Authors:  Maëlle Saunier; Sylvain Monnier-Benoit; Frédéric Mauny; Véronique Dalstein; Jenny Briolat; Didier Riethmuller; Bernadette Kantelip; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

8.  Cervical HPV infection in Romanian women infected with HIV during early childhood.

Authors:  Luminita Ene; Cristina Voinea; Claudia Stefanescu; Diana Sima; Dan Duiculescu; Sanjay R Mehta
Journal:  Int J STD AIDS       Date:  2015-09-24       Impact factor: 1.359

Review 9.  Human papillomavirus related cervical cancer and anticipated vaccination challenges in Ethiopia.

Authors:  TeweldeTesfaye Gebremariam
Journal:  Int J Health Sci (Qassim)       Date:  2016-01

Review 10.  Human papillomavirus-associated cancers: A growing global problem.

Authors:  Anshuma Bansal; Mini P Singh; Bhavana Rai
Journal:  Int J Appl Basic Med Res       Date:  2016 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.